BridgeBio Pharma BBIO
NASDAQ BBIO
$67.25 +0.34 (+0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

BridgeBio Pharma (BBIO) reported Return on Capital Employed [ROCE] of -123.37% for Q2 2026, down 41.83 percentage points from -81.54% a year earlier but up 32.35 percentage points from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, BridgeBio Pharma posted Return on Capital Employed [ROCE] of -81.82%, up 20.69 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +1.13 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -102.51% in FY2024 (+35.26 pp), -137.77% in FY2023 (-64.23 pp), -73.54% in FY2022 (+6.20 pp) and -79.74% in FY2021 (+3.21 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -155.72% in Q1 2026 and a high of -64.44% in Q3 2021.
  • Year over year, Return on Capital Employed [ROCE] gained in four of the last eight quarters, with an average year-over-year change of -2.32 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2024 (a gain of 42.51 percentage points); the low point was Q1 2026 (a drop of 62.50 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -155.72% (Q1 2026), -77.07% (Q4 2025) and -74.14% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 BridgeBio Pharma 13.07 Bn 10.18 Bn 228.63 Mn -123.37%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -123.37%
Mar 31, 2026 -155.72%
Dec 31, 2025 -77.07%
Sep 30, 2025 -74.14%
Jun 30, 2025 -81.54%
Mar 31, 2025 -93.23%
Dec 31, 2024 -92.98%
Sep 30, 2024 -92.19%
Jun 30, 2024 -74.23%
Mar 31, 2024 -86.43%
Dec 31, 2023 -132.95%
Sep 30, 2023 -118.15%
Jun 30, 2023 -116.73%
Mar 31, 2023 -88.05%
Dec 31, 2022 -92.38%
Sep 30, 2022 -81.12%
Jun 30, 2022 -81.69%
Mar 31, 2022 -72.00%
Dec 31, 2021 -75.66%
Sep 30, 2021 -64.44%
API Access

BridgeBio Pharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BBIO&period=max&api_key=YOUR_API_KEY